Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH) has repurchased a total of 3.02% of its shares, costing 136 million yuan.
Shuo Shi Biology (688399.SH) announced that as of September 23, 2024, the company has completed centralized trading...
Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH) announced that as of September 23, 2024, the company has repurchased a total of 1,772,000 shares through centralized bidding trading, accounting for 3.02% of the company's total share capital. The highest purchase price was 80.55 yuan per share, the lowest price was 69.70 yuan per share, and the total amount paid was 136 million yuan (excluding stamp duty, transaction commission, and other transaction fees).
Related Articles
HENGAN INT'L (01044): Li Weiliang has been appointed as Executive Director, Chief Financial Officer, and Authorized Representative.
DAPHNE INT'L (00210) canceled 100,000 shares on September 9.
.png)
MNSO (09896) announced on September 8 that it spent $236,600 to repurchase 101,300 shares.
HENGAN INT'L (01044): Li Weiliang has been appointed as Executive Director, Chief Financial Officer, and Authorized Representative.
DAPHNE INT'L (00210) canceled 100,000 shares on September 9.
MNSO (09896) announced on September 8 that it spent $236,600 to repurchase 101,300 shares.
RECOMMEND
